Study Sponsor:
Bausch Health Americas, Inc
Full IRB Study Title:
A randomized, double-blind, placebo-controlled, dose ranging, parallel-group study of the efficacy and safety of Plecanatide in Children 6 to < 18 Years of Age with Irritable Bowel Syndrome with Constipation (IBS-C) Protocol: SP304202-14
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute,
330-543-3193 or email
research@akronchildrens.org